Common Stock, Value, Issued in USD of Emmaus Life Sciences, Inc. from Q3 2010 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: Emmaus Life Sciences, Inc. quarterly Common Stock, Value, Issued history and change rate from Q3 2010 to Q3 2025.
Emmaus Life Sciences, Inc. Common Stock, Value, Issued for the quarter ending 30 Sep 2025 was $64K, unchanged year-over-year.

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

Emmaus Life Sciences, Inc. Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$64K	$0	0%	30 Sep 2025	10-Q	14 Nov 2025
Q2 2025	$64K	$0	0%	30 Jun 2025	10-Q	14 Aug 2025
Q1 2025	$64K	+$2K	+3.23%	31 Mar 2025	10-Q	15 May 2025
Q4 2024	$64K	+$2K	+3.23%	31 Dec 2024	10-Q	14 Nov 2025
Q3 2024	$64K	+$10K	+18.5%	30 Sep 2024	10-Q	19 Nov 2024
Q2 2024	$64K	+$10K	+18.5%	30 Jun 2024	10-Q	10 Sep 2024
Q1 2024	$62K	+$11K	+21.6%	31 Mar 2024	10-Q	10 Sep 2024
Q4 2023	$62K	+$12K	+24%	31 Dec 2023	10-K	14 Apr 2025
Q3 2023	$54K	+$4K	+8%	30 Sep 2023	10-Q	14 Nov 2023
Q2 2023	$54K	+$4K	+8%	30 Jun 2023	10-Q	14 Aug 2023
Q1 2023	$51K	+$2K	+4.08%	31 Mar 2023	10-Q	15 May 2023
Q4 2022	$50K	+$1K	+2.04%	31 Dec 2022	10-K	03 Jul 2024
Q3 2022	$50K	+$1K	+2.04%	30 Sep 2022	10-Q	14 Nov 2022
Q2 2022	$50K	+$1K	+2.04%	30 Jun 2022	10-Q	15 Aug 2022
Q1 2022	$49K	$0	0%	31 Mar 2022	10-Q	13 May 2022
Q4 2021	$49K	$0	0%	31 Dec 2021	10-K	31 Mar 2023
Q3 2021	$49K	$0	0%	30 Sep 2021	10-Q	12 Nov 2021
Q2 2021	$49K	$0	0%	30 Jun 2021	10-Q	01 Sep 2021
Q1 2021	$49K	$0	0%	31 Mar 2021	10-Q	01 Sep 2021
Q4 2020	$49K	+$1K	+2.08%	31 Dec 2020	10-K	31 Mar 2022
Q3 2020	$49K	+$1K	+2.08%	30 Sep 2020	10-Q	26 Aug 2021
Q2 2020	$49K	+$11K	+28.9%	30 Jun 2020	10-Q	26 Aug 2021
Q1 2020	$49K	+$11K	+28.9%	31 Mar 2020	10-Q	26 Aug 2021
Q4 2019	$48K	+$11K	+29.7%	31 Dec 2019	10-Q	26 Aug 2021
Q3 2019	$48K	+$40.6K	+549%	30 Sep 2019	10-K	25 Jan 2021
Q2 2019	$38K	+$31.7K	+503%	30 Jun 2019	10-Q	26 Aug 2021
Q1 2019	$38K	+$33.6K	+764%	31 Mar 2019	10-Q	26 Aug 2021
Q4 2018	$37K	+$32.6K	+741%	31 Dec 2018	10-K	25 Jan 2021
Q3 2018	$7.4K	+$3.1K	+72.1%	30 Sep 2018	10-Q	14 Aug 2019
Q2 2018	$6.3K	+$3.8K	+152%	30 Jun 2018	10-Q	10 Aug 2018
Q1 2018	$4.4K	+$1.9K	+76%	31 Mar 2018	10-Q	14 May 2018
Q4 2017	$4.4K	+$2.1K	+91.3%	31 Dec 2017	10-Q	20 Feb 2018
Q3 2017	$4.3K	+$2.4K	+126%	30 Sep 2017	10-K	11 Dec 2018
Q2 2017	$2.5K	-$105K	-97.7%	30 Jun 2017	10-Q	14 Aug 2017
Q1 2017	$2.5K	-$100K	-97.6%	31 Mar 2017	10-Q	15 May 2017
Q4 2016	$2.3K	-$100K	-97.8%	31 Dec 2016	10-Q/A	30 Mar 2017
Q3 2016	$1.9K	+$1.4K	+280%	30 Sep 2016	10-K	29 Dec 2017
Q2 2016	$108K	+$5.8K	+5.7%	30 Jun 2016	10-Q	15 Aug 2016
Q1 2016	$103K	+$1K	+0.98%	31 Mar 2016	10-Q	16 May 2016
Q4 2015	$102K	+$700	+0.69%	31 Dec 2015	10-Q	17 Feb 2016
Q3 2015	$500	-$101K	-99.5%	30 Sep 2015	10-K	22 Dec 2016
Q2 2015	$102K	+$1.1K	+1.09%	30 Jun 2015	10-Q	14 Aug 2015
Q1 2015	$102K	+$1.2K	+1.19%	31 Mar 2015	10-Q	18 May 2015
Q4 2014	$102K	+$5.6K	+5.83%	31 Dec 2014	10-Q	13 Feb 2015
Q3 2014	$102K	+$9K	+9.71%	30 Sep 2014	10-K	05 Jan 2016
Q2 2014	$101K	+$50.8K	+102%	30 Jun 2014	10-Q	14 Aug 2014
Q1 2014	$101K	+$70.7K	+237%	31 Mar 2014	10-Q	15 May 2014
Q4 2013	$96.1K	+$94K	+4476%	31 Dec 2013	10-Q	13 Feb 2014
Q3 2013	$92.7K	+$90.8K	+4779%	30 Sep 2013	10-K	29 Dec 2014
Q2 2013	$49.8K	+$47.9K	+2521%	30 Jun 2013	10-Q	14 Aug 2013
Q1 2013	$29.8K	+$27.9K	+1468%	31 Mar 2013	10-Q	15 May 2013
Q4 2012	$2.1K	-$54.1K	-96.3%	31 Dec 2012	10-Q/A	22 Feb 2013
Q3 2012	$1.9K	$0	0%	30 Sep 2012	10-K	23 Dec 2013
Q2 2012	$1.9K	-$54.2K	-96.6%	30 Jun 2012	10-Q/A	11 Sep 2012
Q1 2012	$1.9K			31 Mar 2012	10-Q	15 May 2012
Q4 2011	$56.2K			31 Dec 2011	10-Q	14 Feb 2012
Q3 2011	$1.9K	-$54.1K	-96.6%	30 Sep 2011	10-K	15 Jan 2013
Q2 2011	$56.1K			30 Jun 2011	10-Q/A	09 Sep 2011
Q3 2010	$56K			30 Sep 2010	10-K	22 Dec 2011

* An asterisk sign (*) next to the value indicates that the value is likely invalid.